Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

0.7198 -0.0002 (-0.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,906
Open 0.7198
Bid (Size) 0.7300 (41)
Ask (Size) 0.7500 (1)
Prev. Close 0.7200
Today's Range 0.7198 - 0.7198
52wk Range 0.3040 - 3.179
Shares Outstanding 145,337,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sangamo Therapeutics Announces First Quarter 2025 Earnings Call
From Sangamo Therapeutics, Inc.
Via Business Wire
Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease
From Sangamo Therapeutics, Inc.
Via Business Wire

Performance

YTD
-36.3%
-36.3%
1 Month
+14.7%
+14.7%
3 Month
-43.3%
-43.3%
6 Month
-74.4%
-74.4%
1 Year
+43.3%
+43.3%

More News

Read More
Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
From Sangamo Therapeutics, Inc.
Via Business Wire
Expert Outlook: Sangamo Therapeutics Through The Eyes Of 11 Analysts
Via Benzinga
Friday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert
Via Benzinga
Topics Government
Exposures Political
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday
Via Benzinga
RH, Five Below, Sangamo, Bank Of America, Tesla: Why These 5 Stocks Are On Investors' Radars Amid Trump Tariff Meltdown
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Eli Lilly Stock Drops As Trump Tariff Chaos Hits Markets, But Retail Finds Comfort In Big Pharma’s Exemption
Via Stocktwits
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
What's going on in today's after hours session
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Sangamo Therapeutics Stock Surges After The Bell: What's Going On?
Via Benzinga
Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System
From Sangamo Therapeutics, Inc.
Via Business Wire
8 Analysts Assess Sangamo Therapeutics: What You Need To Know
Via Benzinga
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'
Via Benzinga
IHS Holding, HealthEquity And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Sangamo Therapeutics Retail Traders Keep The Faith Even As Stock Slides After-Hours On Q4 Miss
Via Stocktwits
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
From Sangamo Therapeutics, Inc.
Via Business Wire
Earnings Scheduled For March 17, 2025
Via Benzinga
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference
From Sangamo Therapeutics, Inc.
Via Business Wire
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
Via Benzinga
Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile
From Sangamo Therapeutics, Inc.
Via Business Wire
Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire

Frequently Asked Questions

Is Sangamo Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sangamo Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sangamo Therapeutics, Inc. - Common Stock trade on?
Sangamo Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sangamo Therapeutics, Inc. - Common Stock?
The ticker symbol for Sangamo Therapeutics, Inc. - Common Stock is SGMO on the Nasdaq Stock Market
What is the current price of Sangamo Therapeutics, Inc. - Common Stock?
The current price of Sangamo Therapeutics, Inc. - Common Stock is 0.7198
When was Sangamo Therapeutics, Inc. - Common Stock last traded?
The last trade of Sangamo Therapeutics, Inc. - Common Stock was at 05/08/25 04:00 PM ET
What is the market capitalization of Sangamo Therapeutics, Inc. - Common Stock?
The market capitalization of Sangamo Therapeutics, Inc. - Common Stock is 104.61M
How many shares of Sangamo Therapeutics, Inc. - Common Stock are outstanding?
Sangamo Therapeutics, Inc. - Common Stock has 105M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.